Medtronic PLCNYSE:MDT
- LAST PRICE90.4400
- TODAY'S CHANGE (%)0.3700 (0.4108%)
- Bid / Lots90.4300/ 7
- Ask / Lots90.4700/ 7
- Open / Previous Close90.0300 / 90.0700
- Day Range
- 52 Week Range
- Volume325,672
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MDT |
|---|---|---|
| 09:32 ET | 104022 | 90.03 |
| 09:33 ET | 29119 | 90.375 |
| 09:35 ET | 7467 | 90.42 |
| 09:37 ET | 5469 | 90.36 |
| 09:39 ET | 2475 | 90.38 |
| 09:42 ET | 5324 | 90.24 |
| 09:44 ET | 3491 | 90.29 |
| 09:46 ET | 7339 | 90.11 |
| 09:48 ET | 6421 | 90.2 |
| 09:50 ET | 11421 | 90.29 |
| 09:51 ET | 17164 | 90.12 |
| 09:53 ET | 4507 | 90.12 |
| 09:55 ET | 4718 | 90.26 |
| 09:57 ET | 4656 | 90.325 |
| 10:00 ET | 9926 | 90.3038 |
| 10:02 ET | 9973 | 90.3337 |
| 10:04 ET | 4450 | 90.51 |
Nov 1, 2024
CMS grants Transitional Pass-Through Payment for Medtronic Symplicity Spyral(TM) renal denervation catheter, from 5:23PM ET on Friday Nov 01, 2024 by Dow Jones
5:23PM ET on Friday Nov 01, 2024 by Dow Jones
Oct 28, 2024
SPYRAL HTN-ON MED study shows significant, consistent, long-term blood pressure lowering effect at two years, from 2:15PM ET on Monday Oct 28, 2024 by Dow Jones
2:15PM ET on Monday Oct 28, 2024 by Dow Jones
Oct 25, 2024
DJ Medtronic' Affera, Sphere-9 Offering is Threat to Boston Scientific -- Market Talk, from 9:52AM ET on Friday Oct 25, 2024 by Dow Jones
9:52AM ET on Friday Oct 25, 2024 by Dow Jones
Oct 24, 2024
DJ Medtronic Gets FDA Approval for Affera Technology, from 4:54PM ET on Thursday Oct 24, 2024 by Dow Jones
4:54PM ET on Thursday Oct 24, 2024 by Dow JonesA new paradigm in electrophysiology: Medtronic receives FDA approval of Affera(TM) Mapping and Ablation System and Sphere-9(TM) Catheter, from 4:33PM ET on Thursday Oct 24, 2024 by Dow Jones
4:33PM ET on Thursday Oct 24, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Medtronic PLC | 115.5B | 30.4x | -4.17% |
Stryker Corp | 139.9B | 39.5x | +9.49% |
Becton Dickinson and Co | 68.0B | 47.0x | +11.04% |
Abbott Laboratories | 206.4B | 36.3x | +18.64% |
IDEXX Laboratories Inc | 34.3B | 40.7x | +18.62% |
Baxter International Inc | 18.3B | -117.8x | --- |
Company Information
Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
Contact Information
- Headquarters
- Building Two Parkmore Business Park WestDUBLIN, Ireland 1
- Phone
- ---
- Fax
- ---
Executives
- Executive Chairman of the Board, Chief Executive Officer
- Geoffrey Martha
- Interim Chief Financial Officer
- Gary Corona
- Executive Vice President, General Counsel, Corporate Secretary
- Ivan Fong
- Executive Vice President, President - Medical Surgical Portfolio and Surgical Operating Unit
- Michael Marinaro
- Executive Vice President and President - Cardiovascular Portfolio
- Sean Salmon
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $115.5B |
|---|---|
Revenue (TTM) | $32.6B |
Shares Outstanding | 1.3B |
Dividend Yield | 3.10% |
Annual Dividend Rate | 2.8000 USD |
Ex-Dividend Date | 09-27-24 |
Pay Date | 10-11-24 |
Beta | 0.85 |
EPS | $2.97 |
Book Value | $38.29 |
P/E Ratio | 30.4x |
Price/Sales (TTM) | 3.5 |
Price/Cash Flow (TTM) | 17.5x |
Operating Margin | 15.82% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
